About

Christopher J. DelOrefice was appointed Chief Financial Officer of Ulta Beauty effective December 5, 2025, overseeing the company's accounting, finance, tax, treasury, procurement, and investor relations functions. He joined Ulta Beauty from Becton Dickinson & Company, where he had served as Executive Vice President and Chief Financial Officer since September 2021, and earlier spent more than 20 years at Johnson & Johnson in senior finance roles including Vice President of Investor Relations. He holds B.S. and M.B.A. degrees from Villanova University, is a (inactive) CPA, and serves as a director and audit committee chair of ResMed.

Roles

Ulta Beauty, Inc.
Chief Financial Officer · Current role
2025–present
Becton Dickinson & Company
Executive Vice President & Chief Financial Officer
Johnson & Johnson
Vice President, Investor Relations
AstraZeneca Pharmaceuticals
Finance leadership roles
Ametek, Inc.
Finance leadership roles

External Roles

ResMed Inc.
Director and Audit Committee Chair

Fixed Compensation

FY 2025
Salary
$154,540
ComponentProrated base salary from December 5, 2025 start; annual rate $980,000
Bonus
$1,000,000
FormSign-on / make-whole cash bonus
All other compensation
$13,900
Includes401(k) match $13,800 and other perquisites $100
Total compensation
$4,469,098

Performance Compensation

Data from FY 2025

Cash incentive

Non-equity incentive plan compensation
$0
Target Opportunity
NoteNot eligible for a fiscal 2025 annual incentive given his December 2025 appointment

Stock awards

Stock awards
$3,300,658
FormRestricted stock units, including make-whole equity

Also at Ulta Beauty, Inc.

Related

See how VectorShift works for your firm

Request Demo